News Conference News EACTS 2023 SWEDEHEART Hints at Mortality Benefit With Statins After SAVR Michael O'Riordan October 05, 2023
News Conference News ESC 2023 ESC Endocarditis Guidelines Get First Update in 8 Years Todd Neale August 31, 2023
News Conference News STS 2022 Modified Surgical MV Repair Stands Up to Replacement Michael O'Riordan February 03, 2022
News Conference News STS 2022 Higher Mortality After MV Surgery in Poorer Communities: STS Database Michael O'Riordan February 02, 2022
News Conference News EACTS 2021 More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients Michael O'Riordan October 18, 2021
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
News Conference News TVT 2020 Device Explants After TAVR Rare but Risky Michael O'Riordan June 24, 2020
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
News Conference News ESC 2017 Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days Michael O'Riordan August 31, 2017
News Conference News TVT 2017 Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated Michael O'Riordan June 16, 2017
News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
News Conference News TVT 2016 When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care Michael O'Riordan June 20, 2016
News Conference News ACC 2016 When Chosen Wisely, 90-Year-Olds Do Well After TAVR Caitlin E. Cox April 02, 2016